Molina Healthcare Xarelto Prior Authorization: Navigating DOAC Approvals

Efficiently managing Molina Healthcare Xarelto prior authorization is crucial for ensuring timely patient access to this essential direct oral anticoagulant. Klivira provides the automation and intelligence needed to navigate Molina's state-specific requirements.

For revenue cycle directors and prior authorization coordinators, securing approvals for high-value medications like Xarelto (rivaroxaban) through Molina Healthcare presents unique challenges. This guide details Molina's specific processes, from diverse submission channels to varying state-level utilization management criteria, to help your team optimize PA workflows.

Understanding Molina Healthcare's Prior Authorization for Xarelto (Rivaroxaban)

Xarelto (rivaroxaban) is a direct oral anticoagulant (DOAC) prescribed for critical conditions such as atrial fibrillation and venous thromboembolism (VTE). Molina Healthcare, a significant payer in Medicaid managed care and ACA marketplace plans, requires prior authorization for Xarelto, necessitating a clear understanding of their specific coverage policies and submission pathways.

Xarelto Coverage and Formulary Considerations with Molina Healthcare

As a DOAC, Xarelto's formulary tier and associated requirements, such as step therapy, can vary significantly across Molina Healthcare's state-specific plans. Clinics must consult the relevant state-level Molina formulary and utilization management criteria to determine specific coverage parameters for rivaroxaban, ensuring patient eligibility before submission.

Prior Authorization Submission Channels for Molina Healthcare

  • **Medical Benefit PA:** Submissions for Xarelto under the medical benefit are routed through state-specific provider portals, reflecting Molina's diverse state Medicaid managed-care operations.
  • **Pharmacy Benefit PA:** Molina's pharmacy benefit manager (PBM) relationships are state-specific; retail pharmacy ePA submissions typically leverage platforms like CoverMyMeds and Surescripts ePA.
  • **D-SNP (Dual-Eligible) PA:** For members with both Medicare and Medicaid eligibility, PA workflows combine Medicare Advantage organization-determination rules with state Medicaid coverage rules.
  • **Marketplace PA:** Prior authorizations for Molina's ACA marketplace plans adhere to Qualified Health Plan (QHP) on Federally Facilitated Marketplace (FFM) regulations and state insurance guidelines.

Accessing Molina Healthcare's Utilization Management Criteria for Rivaroxaban

Molina Healthcare publishes its utilization management (UM) criteria for medications like rivaroxaban through state-specific provider websites, accessible via the main molinahealthcare.com provider landing page. It is critical to reference the precise state-specific policy to ensure compliance with coverage rules for Xarelto.

Prior Authorization Turnaround Times and Regulatory Compliance

Prior authorization timeframes for Xarelto with Molina Healthcare are primarily governed by each state's Medicaid managed-care contract. Additionally, Molina's Medicaid managed-care, D-SNP MA, CHIP, and QHP-on-FFM lines are all impacted payers under CMS-0057-F, which mandates specific electronic prior authorization decision timeframes.

Streamlining Molina Healthcare Xarelto Prior Authorizations with Klivira

Klivira's platform provides a robust solution for the complexities of Molina Healthcare Xarelto prior authorizations. Our integration approach incorporates state-aware routing and dynamically applies the correct decision-timeframe expectations per line of business, ensuring that state Medicaid agency rules and Molina's UM operations are seamlessly integrated into your workflow.

Frequently asked questions

What are the primary indications for Xarelto that Molina Healthcare typically covers?

Molina Healthcare typically covers Xarelto (rivaroxaban) for its approved indications, which include the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively known as venous thromboembolism (VTE).

How does Molina Healthcare handle pharmacy versus medical benefit prior authorizations for Xarelto?

Molina Healthcare distinguishes between pharmacy and medical benefit prior authorizations for Xarelto. Pharmacy benefit PAs are often routed through state-specific PBMs, utilizing ePA platforms like CoverMyMeds or Surescripts. Medical benefit PAs, particularly for infusions or specific outpatient uses, are typically submitted via state-specific provider portals.

Where can I find Molina Healthcare's specific utilization management criteria for rivaroxaban?

Molina Healthcare publishes its utilization management (UM) criteria for medications such as rivaroxaban on its state-specific provider websites. Access these resources through the molinahealthcare.com provider landing page, ensuring you select the appropriate state plan for accurate policy details.

Are Molina Healthcare's prior authorization timeframes for Xarelto consistent across all states and plan types?

No, Molina Healthcare's prior authorization timeframes for Xarelto are not consistent across all states or plan types. They are primarily governed by each state's Medicaid managed-care contract and vary based on the line of business (e.g., Medicaid managed care, D-SNP, ACA Marketplace), with CMS-0057-F also impacting decision timeframes.

How does Klivira address the state-specific complexities of Molina Healthcare's Xarelto prior authorizations?

Klivira's integration with Molina Healthcare is designed for state-aware routing, acknowledging the varying requirements of different state Medicaid agencies and Molina's diverse UM operations. Our platform dynamically applies the correct decision-timeframe expectations and submission protocols for each specific line of business, streamlining the PA process.

Related coverage

Other xarelto prior authorization by payer

Other xarelto prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo